Enter multiple symbols separated by commas



  • Medtronic to buy Covidien   Monday, 16 Jun 2014 | 10:10 AM ET
    Medtronic to buy Covidien

    CNBC's Meg Tirrell provides insight to Medtronic's announcement it will buy Covidien, and also discusses the consolidation trends in medical device companies.

  • PCLN global expertise to help OPEN?   Friday, 13 Jun 2014 | 11:00 AM ET
    PCLN global expertise to help OPEN?

    Kara Swisher, Re/code co-executive editor, discusses if Priceline's purchase of OpenTable makes sense. Swisher says Priceline wants to expand and OpenTable will help them grow globally. CNBC's Jon Fortt provides insight.

  • PCLN will help OPEN expand internationally: Pro   Friday, 13 Jun 2014 | 10:17 AM ET
    PCLN will help OPEN expand internationally: Pro

    Mark May, Citigroup, explains why he likes Priceline's announced acquisition of OpenTable for $2.6 billion. May says "from a valuation standpoint, it is very reasonable."

  • Behind the Merck-Idenix deal   Monday, 9 Jun 2014 | 10:06 AM ET
    Behind the Merck-Idenix deal

    Merck is buying Idenix Pharmaceuticals for $3.85 billion in a deal that has already been approved by the boards of both companies, reports CNBC's Meg Tirrell.

  • SPAC on track to write 'blank check'   Friday, 6 Jun 2014 | 7:38 AM ET
    SPAC on track to write 'blank check'

    Billionaire investor Wilbur Ross, WL Ross & Company chairman and CEO, discusses the launch of his publicly traded special purpose acquisition corporation, formed for the purpose of making acquisition.

  • Sprint, T-Mobile deal not official yet   Thursday, 5 Jun 2014 | 1:34 PM ET
    Sprint, T-Mobile deal not official yet

    A quick rundown of the action going on in the telecom industry, with CNBC's Morgan Brennan. The big question is whether regulators will agree with a merger for T-Mobile and Sprint.

  • Sprint, T-Mobile & the state of US broadband   Thursday, 5 Jun 2014 | 11:03 AM ET
    Sprint, T-Mobile & the state of US broadband

    CNBC's Jon Fortt and Henry Blodget, Business Insider editor-in-chief & CEO, discuss the potential deal between Sprint and T-Mobile and what it means for the state of broadband in the U.S. Blodget says both companies are at a tremendous disadvantage and need the scale to compete.

  • Andreessen on Apple   Thursday, 5 Jun 2014 | 7:19 AM ET
    Andreessen on Apple

    Marc Andreessen, Andreessen Horowitz, shares his thoughts on Apple's future after Steve Jobs and the acquisition of Beats. Jimmy Iovine is one of the best entrepreneurs of our time, says Andreessen.

  • Fight for Hillshire   Tuesday, 3 Jun 2014 | 9:02 AM ET
    Fight for Hillshire

    Pilgrim's Pride is sweetening its takeover offer for Hillshire Brands. CNBC's Jim Cramer and David Faber discuss the "insane" bidding for Hillshire.

  • Music the right battle for Apple?   Thursday, 29 May 2014 | 11:03 AM ET
    Music the right battle for Apple?

    CNBC's Jon Fortt and Liz Gannes, Re/code senior editor, discuss what Jimmy Iovine brings to Apple and if music is really that important to the tech giant's future.

  • Apple all about option value: Pro   Thursday, 29 May 2014 | 10:04 AM ET
    Apple all about option value: Pro

    Toni Sacconaghi, Sanford C. Bernstein senior research analyst, discusses what the Beats deal means for Apple and if this was the best decision for the tech giant to invest its capital.

  • Pilgrim's Pride offers to buy Hillshire for $45/share

    "Squawk Box" host Andrew Ross Sorkin has the latest details on Pilgrim's Pride's bid for Hillshire Brands.

  • Carlson sells TGI Fridays, reportedly for $800M Tuesday, 20 May 2014 | 4:39 PM ET

    The sale of the 49-year-old restaurant chain is expected to close in July. TGI Fridays employs over 70,000 people globally.

  • Google in talks to buy Twitch   Monday, 19 May 2014 | 12:55 PM ET
    Google in talks to buy Twitch

    YouTube is reportedly ready to make its largest acquisition ever. CNBC's Josh Lipton provides insight to the potential deal.

  • AstraZeneca Chair: Shareholders, 'vote me away' Monday, 19 May 2014 | 11:14 AM ET

    As AstraZeneca's shares slid following its rejection of Pfizer's new bid, the company's chairman said he was "reasonably confident" it was the right decision.

  • Apple-Beats 'huge culture clash': Strategist   Friday, 9 May 2014 | 3:30 PM ET
    Apple-Beats 'huge culture clash': Strategist

    Max Wolff, Citizen V.C. chief economist; Yukari Kane, author of "Haunted Empire: Apple After Steve Jobs"; and David Nelson, Belpointe Asset Management.

  • Beats could be biggest Apple buy   Friday, 9 May 2014 | 3:26 PM ET
    Beats could be biggest Apple buy

    A look at Apple's could-be deal with Beats Electronics, with CNBC's Morgan Brennan.

  • Hip hop millionaires   Friday, 9 May 2014 | 2:52 PM ET
    Hip hop millionaires

    CNBC's Robert Frank reports on the race to be hip hop's first billionaire.

  • Songza CEO says industry 'young'   Friday, 9 May 2014 | 2:48 PM ET
    Songza CEO says industry 'young'

    Discussing competition in the music streaming space, and what a potential deal between Apple and Beats Electronics could mean for the industry, with Elias Roman, Songza co-founder & CEO.

  • Potential Apple-Beats deal   Friday, 9 May 2014 | 1:19 PM ET
    Potential Apple-Beats deal

    CNBC has learned Apple is in talks to buy headphone maker Beats Electronics for $3.2 billion. CNBC contributor Natalie Morris, and Peter Kafka, Re/code senior editor, discuss.